DOCSLIB.ORG

Tissue Factor Deficiency Causes Cardiac Fibrosis and Left Ventricular Dysfunction

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Tissue Factor Deficiency Causes Cardiac Fibrosis and Left Ventricular Dysfunction Tissue factor deficiency causes cardiac fibrosis and left ventricular dysfunction R. Pawlinski*, A. Fernandes*, B. Kehrle*, B. Pedersen*, G. Parry*, J. Erlich†, R. Pyo‡, D. Gutstein‡, J. Zhang‡, F. Castellinoʈ, E. Melis§, P. Carmeliet§, G. Baretton¶, T. Luther¶, M. Taubman‡, E. Rosenʈ, and N. Mackman*,** *Department of Immunology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037; †Department of Nephrology, University of New South Wales, Prince of Wales Hospital, High Street, Sydney 2052, Australia; ‡Department of Medicine and Molecular Biology, Mount Sinai Medical Center, One Gustave L. Levy Place, Box 1269, New York, NY 10029; §Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology (VIB), KU Leuven, B-3000 Leuven, Belgium; ¶Institut fu¨r Pathologie, Universita¨tsklinikum Carl Gustav Carus der Technischen Universita¨t, 01307 Dresden, Germany; and ʈDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN 46556 Edited by Philip W. Majerus, Washington University School of Medicine, St. Louis, MO, and approved October 4, 2002 (received for review August 20, 2002) Exposure of blood to tissue factor (TF) activates the extrinsic Materials and Methods (TF:FVIIa) and intrinsic (FVIIIa:FIXa) pathways of coagulation. In this Mice. Low-TF mice (line 47) were analyzed on either a mixed Ϸ study, we found that mice expressing low levels of human TF ( 1% genetic background (62.5% C57BL͞6J, 25% 129Sv, and 12.5% ؊/؊ of wild-type levels) in an mTF background had significantly BALB͞c) or a C57BL͞6J background (Ն97%). mTF⌬cyt/⌬cyt shorter lifespans than wild-type mice, in part, because of sponta- mice express normal levels of murine TF lacking the cytoplasmic neous fatal hemorrhages. All low-TF mice exhibited a selective domain (17). Low murine FVII mice (FVIItTA-FVII/tTA-FVII) were heart defect that consisted of hemosiderin deposition and fibrosis. generated by replacing the entire FVII gene with a transgene Direct intracardiac measurement demonstrated a 30% reduction expressing FVII under the control of a tTA responsive promoter (P < 0.001) in left ventricular function in 8-month-old low-TF (E.R., Z. Liang, A. Martin, and F.C., unpublished data). FbgϪ/Ϫ mice compared with age-matched wild-type mice. Mice expressing Ϫ Ϫ and FIX / mice have been described (11, 18). All studies were low levels of murine FVII (Ϸ1% of wild-type levels) exhibited a approved by The Scripps Research Institute Animal Care and similar pattern of hemosiderin deposition and fibrosis in their Use Committee and comply with National Institutes of Health hearts. In contrast, FIX؊/؊ mice, a model of hemophilia B, had guidelines. normal hearts. Cardiac fibrosis in low-TF and low-FVII mice appears to be caused by hemorrhage from cardiac vessels due to impaired Measurement of Cell Counts and Clotting Activity. White cell, red hemostasis. We propose that TF expression by cardiac myocytes cell and platelet counts, and hemoglobin and hematocrit levels provides a secondary hemostatic barrier to protect the heart from were determined by LabCorp (San Diego), using blood collected hemorrhage. from the inferior vena cava. Activated partial thromboplastin times (APTTs) and prothrombin times (PTs) were performed xpression of tissue factor (TF) by adventitial fibroblasts and using Automated APTT Reagent and Thromboplastin Reagent BIOCHEMISTRY Evascular smooth muscle cells surrounding blood vessels (Organon Teknika), respectively, and clotting times determined provides a hemostatic barrier that activates coagulation when using a START4 Coagulation Analyzer (Diagnostica Stago, vascular integrity is disrupted (1). TF is also expressed by cardiac Parsippany, NJ). Levels of TAT in the plasma were determined muscle but not by skeletal muscle (1). TF functions as the ͞ using a commercial ELISA (Enzygnost, Dade Behring, Marburg, high-affinity cellular receptor for FVII VIIa (2). The coagula- Germany). The procoagulant activity of heart tissue extracts tion protease cascades are comprised of the extrinsic (TF:FVIIa) added to mouse plasma was determined using a one-stage and intrinsic (FVIIIa:FIXa) pathways, which together maintain clotting assay as described (13) and converted to activity units by hemostasis (3). comparison to a standard curve generated using mouse brain Many murine models of coagulation have been generated that thromboplastin. Factor VII assays were performed using a provide new insights into the role of the various procoagulant modification of the Coaset FVII assay (Chromogenix, Milan). A and anticoagulant proteins in hemostasis (4). For instance, standard curve was generated by combining wild-type mouse FVLeiden/Leiden mice, which express an FV variant that is resistant plasma with human FX-deficient plasma at varying ratios. to inactivation by activated protein C, and TMPro/Pro mice, which express a mutated version of thrombomodulin (TM) with re- Histology. Tissue sections were stained with hematoxylin͞eosin duced thrombin binding, both exhibit prothrombotic phenotypes (H&E), Prussian Blue, or Masson’s Trichrome. Macrophages with increased fibrin deposition in select tissues (5–7). Mice with were identified with a monoclonal antibody MOMA-2 (1:1,000; prohemorrhage phenotypes include models of hemophilia A (FVIIIϪ/Ϫ) and B (FIXϪ/Ϫ), as well as fibrinogen-deficient mice Serotec; ref. 20). (FbgϪ/Ϫ) and thrombocytopenic mice (NF-E2Ϫ/Ϫ) (8–12). Mice Measurement of Left Ventricular (LV) Function of the Hearts of Low-TF with complete deficiencies in TF, FVII, FX, FV, and prothrom- Mice. bin die in utero or shortly after birth (4). We and others have LV function of hearts of low-TF mice (8 months of age) and Ͻ age-matched C57BL͞6J mice was measured as described (20). generated mice expressing low levels ( 0.1–1% of wild-type ͞ levels) of human TF, murine FVII, and murine FV (13–15). We LV function (dp dt) and LV systolic pressures were obtained at have shown that low-TF mice have impaired uterine hemostasis a constant heart rate range of 480–510. The heart rate was (16). A similar phenotype is observed with low-FVII mice. decreased by increasing the level of isoflurane anesthesia. In this study, we performed a detailed characterization of low-TF mice. These mice exhibited shorter lifespans than wild- This paper was submitted directly (Track II) to the PNAS office. type mice. Histological analysis of various tissues of low-TF mice Abbreviations: Fbg, fibrinogen; H&E, hematoxylin͞eosin; LV, left ventricular; TF, tissue revealed hemosiderin deposition and fibrosis selectively in their factor. hearts. Our data suggest that cardiac fibrosis in low-TF mice is **To whom correspondence should be addressed at: Departments of Immunology and Cell caused by hemorrhage from cardiac vessels due to impaired Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, C-204, La Jolla, hemostasis. CA 92037. E-mail: [email protected]. www.pnas.org͞cgi͞doi͞10.1073͞pnas.242501899 PNAS ͉ November 26, 2002 ͉ vol. 99 ͉ no. 24 ͉ 15333–15338 Downloaded by guest on September 30, 2021 Table 1. Clotting activity in low-TF mice Genotype mTFϩ/ϩ mTFϩ/Ϫ͞hTFϩ mTFϪ/Ϫ͞hTFϩ Heart PCA, arbitrary units 232 Ϯ 80 (3) 98 Ϯ 80 (3) 0.2 Ϯ 0.2 (3) PT, s 10.47 Ϯ 0.15 (3) 10.48 Ϯ 0.05 (4) 10.53 Ϯ 0.32 (4) APTT, s 26.37 Ϯ 0.90 (3) 29.85 Ϯ 0.76 (4) 31.53 Ϯ 0.90 (4) TAT, ng͞ml 1.78 Ϯ 0.44 (3) 0.74 Ϯ 0.28 (5) 0.04 Ϯ 0.02 (5) PT, prothrombin time; APTT, activated partial thromboplastin time; PCA, procoagulant activity. Numbers in parentheses indicate the number of mice used in each analysis. Data Analysis. Statistical analysis was performed using a two- and then became widespread throughout the myocardium tailed unpaired Student’s t test, and differences were determined (Fig. 2B). to be statistically significant at a P value of Ͻ0.05. Decreased LV Function in the Hearts of Low-TF Mice. Hemodynamic Results studies revealed that low-TF mice had a marked impairment of Characterization of Low-TF Mice. Low-TF mice (mTFϪ/Ϫ͞hTFϩ heart contractility manifested by a significant decrease in dp͞dt line 47) contain a minigene (hTF) that directs cell type-specific at every heart rate examined (Fig. 3). At normal mouse heart expression of human TF that is similar to the expression of rates (480–510 beats per min), the dp͞dt and the LV pressure murine TF (13). Immunohistochemical analysis indicated that were decreased by 30% (P Ͻ 0.001). These results indicate that human TF was expressed by adventitial cells surrounding blood the cardiac fibrosis in the hearts of low-TF mice significantly vessels (data not shown). However, quantitation of the proco- impairs LV function. agulant activity of tissue extracts from various tissues indicated that these mice expressed low levels of TF (Ϸ1% of wild-type Detailed Histological Analysis of the Hearts of Low-TF Mice. We levels; ref. 13). For example, the procoagulant activity of tissue examined hearts from Ͼ100 low-TF mice at different ages. We extracts from hearts of low-TF mice was very low compared with observed golden-brown granular deposits in the myocardium in control mice (Table 1), indicating a deficiency of TF in the heart. tissue sections stained with H&E (Fig. 4A). We suspected that We evaluated the clotting activity and response to hemostatic these deposits were hemosiderin, which is an insoluble protein challenge of low-TF mice (4–8 weeks of age) on a C57BL͞6J produced by phagocyte digestion of hematin. We used Prussian background. No significant differences were found in whole Blue staining to confirm the presence of iron in the deposits in blood samples collected from low-TF mice (n ϭ 5) and serial sections (Fig. 4B). Immunohistochemical studies showed ϩ Ϫ ϩ mTF / ͞hTF (n ϭ 5) littermate mice with regard to platelet, that the hemosiderin-laden cells stained with MOMA-2 (not red cell, and white cells counts, and hematocrit and hemoglobin shown), which specifically recognizes macrophages (19).
Load more

Recommended publications
  • Section 8: Hematology CHAPTER 47: ANEMIA
    Section 8: Hematology CHAPTER 47: ANEMIA Q.1. A 56-year-old man presents with symptoms of severe dyspnea on exertion and fatigue. His laboratory values are as follows: Hemoglobin 6.0 g/dL (normal: 12–15 g/dL) Hematocrit 18% (normal: 36%–46%) RBC count 2 million/L (normal: 4–5.2 million/L) Reticulocyte count 3% (normal: 0.5%–1.5%) Which of the following caused this man’s anemia? A. Decreased red cell production B. Increased red cell destruction C. Acute blood loss (hemorrhage) D. There is insufficient information to make a determination Answer: A. This man presents with anemia and an elevated reticulocyte count which seems to suggest a hemolytic process. His reticulocyte count, however, has not been corrected for the degree of anemia he displays. This can be done by calculating his corrected reticulocyte count ([3% × (18%/45%)] = 1.2%), which is less than 2 and thus suggestive of a hypoproliferative process (decreased red cell production). Q.2. A 25-year-old man with pancytopenia undergoes bone marrow aspiration and biopsy, which reveals profound hypocellularity and virtual absence of hematopoietic cells. Cytogenetic analysis of the bone marrow does not reveal any abnormalities. Despite red blood cell and platelet transfusions, his pancytopenia worsens. Histocompatibility testing of his only sister fails to reveal a match. What would be the most appropriate course of therapy? A. Antithymocyte globulin, cyclosporine, and prednisone B. Prednisone alone C. Supportive therapy with chronic blood and platelet transfusions only D. Methotrexate and prednisone E. Bone marrow transplant Answer: A. Although supportive care with transfusions is necessary for treating this patient with aplastic anemia, most cases are not self-limited.
    [Show full text]
  • The Nature of Storage Iron in Idiopathic Hemochromatosis and in Hemosiderosis
    THE NATURE OF STORAGE IRON IN IDIOPATHIC HEMOCHROMATOSIS AND IN HEMOSIDEROSIS ELECTRON OPTICAL, CHEMICAL, AND SEROLOGIC STUDIES ON ISOLATED HEMOSIDERIN GRANULES* BY GOETZ W. RICHTER, M.D. (From the Department of Pathology, Cornell University Medical College, New York) PLATES 47 TO 51 (Received for publication, April 21, 1960) Although ferritin has long been recognized as an important iron storage compound and as an intermediary in normal iron metabolism, its role in idiopathic hemochromatosis and in secondary hemosiderosis is still unkuown. Diverse means have been employed to gain more knowledge on the pathway of iron in these conditions, and numerous publications attest the difficulties inherent in trying to distinguish between normal and abnormal storage of iron in cells of various sorts. Histochemical studies have provided evidence that inorganic compounds of iron stored in cells as hemosiderin are combined with an organic carrier substance that contains variable quantities of protein, lipid, and carbohydrate (1, 2). Results of chemical analyses led Ludewig to emphasize the heterogeneity of hemosiderin granules (3); his findings have provided qualitative and quantitative data on the carbohydrate, lipid, protein, and iron content of various hemosiderin preparations. The term "hemosiderin" has been used rather loosely; generally it refers to granules that are visible in the light micro- scope, brown when unstained, and give a positive Prussian blue test. Iron that gives a positive Prussian blue test with potassium ferrocyanide without the previous application of oxidizing agents must be in the trivalent (ferric) state. This is true of the bulk of iron in hemosiderin granules; it is also true of the iron hydroxide present in ferritin (4, 5, 7).
    [Show full text]
  • Visualization of Microbleeds with Optical Histology in Mouse Model of Cerebral Amyloid Angiopathy
    Microvascular Research 105 (2016) 109–113 Contents lists available at ScienceDirect Microvascular Research journal homepage: www.elsevier.com/locate/ymvre Visualization of microbleeds with optical histology in mouse model of cerebral amyloid angiopathy Patrick Lo a,b, Christian Crouzet a,b, Vitaly Vasilevko c,1,BernardChoia,b,d,⁎,1 a Beckman Laser Institute and Medical Clinic, University of California, Irvine, 1002 Health Sciences Road East, Irvine, CA 92612, USA b Department of Biomedical Engineering, University of California, Irvine, 3120 Natural Sciences II, Irvine, CA 92697, USA c Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, 1207 Gillespie NRF, Irvine, CA 92697-4540, USA d Edwards Lifesciences Center for Advanced Cardiovascular Technology, University of California, Irvine, 2400 Engineering Hall, Irvine, CA 92697, USA article info abstract Article history: Cerebral amyloid angiopathy (CAA) is a neurovascular disease that is strongly associated with an increase in the Received 14 May 2015 number and size of spontaneous microbleeds. Conventional methods of magnetic resonance imaging for detec- Revised 3 February 2016 tion of microbleeds, and positron emission tomography with Pittsburgh Compound B imaging for amyloid Accepted 4 February 2016 deposits, can separately demonstrate the presence of microbleeds and CAA in affected brains in vivo;however, Available online 10 February 2016 there still is a critical need for strong evidence that shows involvement of CAA in microbleed formation. Here, we show in a Tg2576 mouse model of Alzheimer's disease, that the combination of histochemical staining and Keywords: Intracerebral hemorrhage an optical clearing method called optical histology, enables simultaneous, co-registered three-dimensional visu- DiI alization of cerebral microvasculature, microbleeds, and amyloid deposits.
    [Show full text]
  • Brain Metastasis from Unknown Primary Tumour: Moving from Old Retrospective Studies to Clinical Trials on Targeted Agents
    cancers Review Brain Metastasis from Unknown Primary Tumour: Moving from Old Retrospective Studies to Clinical Trials on Targeted Agents Roberta Balestrino 1,* , Roberta Rudà 2,3 and Riccardo Soffietti 3 1 Department of Neuroscience, University of Turin, Via Cherasco 15, 10121 Turin, Italy 2 Department of Neurology, Castelfranco Veneto/Treviso Hospital, Via dei Carpani, 16/Z, 31033 Castelfranco Veneto, Italy; [email protected] 3 Department of Neuro-Oncology, University of Turin, Via Cherasco 15, 10121 Turin, Italy; riccardo.soffi[email protected] * Correspondence: [email protected] Received: 13 October 2020; Accepted: 9 November 2020; Published: 12 November 2020 Simple Summary: Brain metastases (BMs) are the most common intracranial tumours in adults and occur up to 3–10 times more frequently than primary brain tumours. In up to 15% of patients with BM, the primary tumour cannot be identified. These cases are known as BM of cancer of unknown primary (CUP) (BM-CUP). The understanding of BM-CUP, despite its relative frequency and unfavourable outcome, is still incomplete and clear indications on management are missing. The aim of this review is to summarize current evidence on the diagnosis and treatment of BM-CUP. Abstract: Brain metastases (BMs) are the most common intracranial tumours in adults and occur up to 3–10 times more frequently than primary brain tumours. BMs may be the cause of the neurological presenting symptoms in patients with otherwise previously undiagnosed cancer. In up to 15% of patients with BMs, the primary tumour cannot be identified. These cases are known as BM of cancer of unknown primary (CUP) (BM-CUP).
    [Show full text]
  • Urine Hemosiderin: a Novel Marker to Assess the Severity of Chronic Venous Disease
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Urine hemosiderin: A novel marker to assess the severity of chronic venous disease Paolo Zamboni, MD,a Marcello Izzo, MD,a Luisella Fogato, MD,a Sergio Carandina, MD,a and Vincenzo Lanzara, PhD,b Ferrara, Italy Objective: Impaired venous drainage in severe chronic venous insufficiency (CVI) leads to microcirculatory overload, characterized by erythrocyte diapedesis and subsequent extravascular hemolysis, resulting in typical dermal hemosiderin deposition. We hypothesized that hemosiderin, normally absent, could be present in the urine in CVI. Methods: The three-phase study included 117 patients with CVI and 12 healthy control subjects, all of whom had undergone clinical examination and duplex scanning. In phase 1, current methods were used to test urine for hemosiderin in 61 persons: 12 healthy control subjects, 24 patients with mild CVI (clinical class C1 to C3), and 25 patients with severe CVI (clinical class C4 to C6). In phase 2, the concentration of urinary hemosiderin was determined in 45 consecutive patients with CVI, CEAP class 1 to 6. A score of 0 was assigned when typical hemosiderin granules were absent at microscopic examination, a score of 1 when one to three granules per field were detected; 2 when four to six granules were detected; and 3 when more than six granules were observed. Phase 3 included 23 patients with CVI (clinical class 2 to 6). Hemosiderin concentration was determined and a score assigned before patients underwent surgical procedures to correct primary CVI. Both hemosiderin testing and duplex scanning were repeated after 6 months.
    [Show full text]
  • The Biophysical Role of Hemodynamics in the Pathogenesis of Cerebral Aneurysm Formation and Rupture
    NEUROSURGICAL FOCUS Neurosurg Focus 47 (1):E11, 2019 The biophysical role of hemodynamics in the pathogenesis of cerebral aneurysm formation and rupture Sauson Soldozy, BA, Pedro Norat, MD, Mazin Elsarrag, MS, Ajay Chatrath, MS, John S. Costello, BA, Jennifer D. Sokolowski, MD, PhD, Petr Tvrdik, PhD, M. Yashar S. Kalani, MD, PhD, and Min S. Park, MD Department of Neurological Surgery, University of Virginia Health System, Charlottesville, Virginia The pathogenesis of intracranial aneurysms remains complex and multifactorial. While vascular, genetic, and epidemio- logical factors play a role, nascent aneurysm formation is believed to be induced by hemodynamic forces. Hemodynamic stresses and vascular insults lead to additional aneurysm and vessel remodeling. Advanced imaging techniques allow us to better define the roles of aneurysm and vessel morphology and hemodynamic parameters, such as wall shear stress, oscillatory shear index, and patterns of flow on aneurysm formation, growth, and rupture. While a complete understand- ing of the interplay between these hemodynamic variables remains elusive, the authors review the efforts that have been made over the past several decades in an attempt to elucidate the physical and biological interactions that govern aneurysm pathophysiology. Furthermore, the current clinical utility of hemodynamics in predicting aneurysm rupture is discussed. https://thejns.org/doi/abs/10.3171/2019.4.FOCUS19232 KEYWORDS cerebral aneurysm; hemodynamics; wall shear stress; computational fluid dynamics; vascular remodeling NTRACRANIAL aneurysms (IAs) are acquired outpouch- cades and, ultimately, a wide range of transcriptional and ings of arteries that occur in 1%–2% of the popula- signaling changes that lead to vascular wall remodeling. tion.36 Likely as a result of improved imaging modali- The advent of computational and radiographic modeling Ities, the incidence of unruptured IAs has increased.
    [Show full text]
  • Path Pulmonary Outline
    Pathology Pulmonary ATELECTASIS Neonatal Atelectasis ‐ The lungs of the neonate never inflate, a consequence of congenital defect, premature birth (insufficient surfactant), or other consequence, also called Patchy Atelectasis Adult or Acquired Atelectasis ‐ Collapse of Previously Inflated lung, creating areas of “airless parenchyma” ‐ Produces a well‐perfused but poorly‐ventilated region, predisposing for infection Decreased Volume ‐ Is a reversible disorder (except in the case of contraction) outside pleural space ‐ Resorption Atelectasis o Consequence of complete obstruction without impairment to blood flow Blockage o A decreased lung volume results in a mediastinal shift towards affected lung o Caused by a mucous plug associated with Asthma, Bronchitis, or Aspiration Pneumonia ‐ Compression Atelectasis o Consequence of partially or totally filled pleura with exudate (CHF), tumor, air (pneumothorax), blood (hemothorax), when air pressure threatens the function of lungs and great vessels (tension pneumothorax), or with an extra‐pulmonary mass compressing Something within lung parenchyma. pleural space compressing o Compressed lung tissue cannot expand and is therefore poorly ventilated. parenchyma o Compression pushes lung resulting in a mediastinal shift away from affected lung ‐ Contraction Atelectasis o Fibrotic changes prevent expansion, resulting in reduced lung volume and ventilation Fibrotic o This form is irreversible Changes are Irreversible PULMONARY EDEMA Pulmonary Edema is simply the accumulation of fluid in the alveolar
    [Show full text]
  • Hemosiderin-Laden Macrophages Are an Independent Factor Correlated with Pulmonary Vascular Resistance in Idiopathic Pulmonary Fi
    Fukihara et al. BMC Pulmonary Medicine (2017) 17:30 DOI 10.1186/s12890-017-0376-8 RESEARCHARTICLE Open Access Hemosiderin-laden macrophages are an independent factor correlated with pulmonary vascular resistance in idiopathic pulmonary fibrosis: a case control study Jun Fukihara1, Hiroyuki Taniguchi1*, Masahiko Ando2, Yasuhiro Kondoh1, Tomoki Kimura1, Kensuke Kataoka1, Taiki Furukawa1, Takeshi Johkoh3, Junya Fukuoka4, Koji Sakamoto5 and Yoshinori Hasegawa5 Abstract Background: Increases in hemosiderin-laden macrophages (HLM) are reported to be observed in idiopathic pulmonary fibrosis (IPF). According to a recent study, significant correlation between hemosiderin deposition in the lung tissue of IPF and pulmonary hypertension evaluated by echocardiography has been suspected. In this study, we aimed to evaluate whether HLM in bronchoalveolar lavage fluid (BALF) is a factor correlated with pulmonary hemodynamic parameters evaluated by right heart catheterization in patients with IPF. Methods: Initial data from 103 consecutive patients with IPF who underwent surgical lung biopsy between November 2007 and March 2014 were retrospectively analyzed. The “HLM score” of BALF was established by dividing the number of Perls’ Prussian blue stain positive macrophages by the total number of macrophages counted. Results: BALF showed an elevated HLM score (38.2%). Right heart catheterization revealed mean pulmonary arterial pressure (mPAP) of 16.3 mmHg and pulmonary vascular resistance (PVR) of 1.55 Wood units. HLM score was positively correlated with mPAP (ρ = 0.204; p = 0.038) and PVR (ρ = 0.349, p < 0.001). In multivariate analysis, 6-min walk distance (standardized partial regression coefficient [β], −0.391; p < 0.001), minimum oxygen saturation during 6-min walk distance (β, −0.294; p = 0.001) and HLM score (β, 0.265; p = 0.002) were independently correlated with PVR.
    [Show full text]
  • Iron Overload Syndromes and the Liver
    Modern Pathology (2007) 20, S31–S39 & 2007 USCAP, Inc All rights reserved 0893-3952/07 $30.00 www.modernpathology.org Iron overload syndromes and the liver Kenneth P Batts Pathology Lab, Division of Gastrointestinal Pathology, Minnesota Gastroenterology, Abbott Northwestern Hospital, Minneapolis, MN, USA Iron can accumulate in the liver in a variety of conditions, including congenital, systemic iron-loading conditions (hereditary hemochromatosis), conditions associated with systemic macrophage iron accumulation (transfusions, hemolytic conditions, anemia of chronic disease, etc), in some hepatitidies (hepatitis C, alcoholic liver disease, porphyria cutanea tarda), and liver-specific iron accumulation of uncertain pathogenesis in cirrhosis. The anatomic pathologist will be faced with the task of determining whether iron accumulation in the liver is significant and, if so, the nature of the disease that lead to the accumulation (ie diagnosis). The tools available to the pathologist include (most importantly) histologic examination with iron stain, quantitative iron analysis, clinical history, laboratory iron tests (serum iron and iron-binding capacity, serum ferritin) and germline genetic analysis for mutations in genes known to be associated with hemochromatosis (HFE, ferroportin, hepcidin, hemojuvelin, transferrin receptor-2). This article provides an overview of the above. Modern Pathology (2007) 20, S31–S39. doi:10.1038/modpathol.3800715 Keywords: liver; iron; hemochromatosis; review Overview and definitions based on the presence of a combination of an otherwise unexplained iron overload, frequent Iron can accumulate in the liver in a wide variety of presence of iron overload in relatives, and in later conditions (Table 1), the clinically most important of stages end-organ damage (liver, pancreas, etc). which is hereditary hemochromatosis (HH).
    [Show full text]
  • Hemochromatosis: Introduction
    Hemochromatosis: Introduction Hemochromatosis was first identified in the 1800s, and by 1935 it was understood to be an inherited disease resulting in iron overload and deposition. Today, hemochromatosis is defined as a metabolic disorder affecting iron absorption , and resulting in the accumulation of excess iron in the body’s organs. Hereditary hemochromatosis (HH) is an autosomal recessive disorder that affects one in three hundred people in the United States. One in nine people carry the gene —making hemochromatosis the most common genetic disorder in the United States. It is primarily seen in middle-aged men of Northern European descent, and postmenopausal women. Treatment is readily available and the prognosis , with early diagnosis and proactive treatment, is a normal life expectancy. If untreated, hemochromatosis may lead to cirrhosis . Figure 1. Location of the liver in the body. What is Hemochromatosis? Despite being the most prevalent monoallelic genetic disease in Caucasians, hereditary hemochromatosis is under-diagnosed. There are several reasons for this, including lack of awareness, a long latency period, and nonspecific symptoms. Figure 2. Deposition of iron in the liver; A, Gross liver; B, Histological view. Normal iron absorption occurs in the proximal small intestine at a rate of 1-2 mg per day. In people with hereditary hemochromatosis, this absorption rate can reach 4–5 mg per day with progressive accumulation to 15–40 grams of iron in the body (Figure 2). Humans have no physiologic pathway to excrete iron. Therefore, iron can accumulate in any body tissue, although depositions are most common in the liver, thyroid, heart, pancreas, gonads, hypothalamus and joints.
    [Show full text]
  • Hematology and Immunology a Concise Update Adlette Inati MD Pediatric Hematology Oncology Lebanese American University and Rafik Hariri University Hospital
    Hematology and Immunology A concise update Adlette Inati MD Pediatric Hematology Oncology Lebanese American University and Rafik Hariri University Hospital Lebanese University Oct 25, 2013 Learning Objectives Concisely Review Anemia Hematopoietic and Stromal Cell Differentiation Erythropeisis Main players Pluripotent stem cells Chemical regulators Cytokines Erythroid specific growth factor Erythropoietin (EPO) Thyroid hormones, estrogens and androgens Nutritional requirements Proteins and amino acids Vitamin B12 and folic acid Vitamin B6 (pyridoxine) Iron Other nutrients (Vitamin C, cupper, cobalt) Anemia Diagnosis History Physical Examination Blood count Blood smear Reticulocyte count Medical History Sudden onset of pallor, fatigue or exercise intolerance? Blood loss, easy bruisability? Cold intolerance, constipation, lethargy, poor growth Recent drug or fava bean intake or viral infection? Neonatal jaundice or episodes of jaundice or dark urine in the past? The child’s diet? Any iron supplements? Any history of pica? Any history of recurrent bone or joint pain or diarrhea? Family History Anemia or low blood counts? Excessive bleeding, transfusion requirements ? Splenectomy ,cholecystectomy, hystereectomy at an early age? Autoimmune diseases ? Consanguinity? Ethnic / geographical origin? Physical Examination Is the child active and playful or fatigued? Look for pallor, signs of heart failure, icterus, jaundice, glossitis Look for petechiae, bruises, splenomegaly, pathologic lymphadenopathy, abdominal masses,
    [Show full text]
  • Prussian Blue - Nuclear Fast Red Staining Kit
    Prussian Blue - nuclear fast red staining kit Cat.No.：E670110 Package：100 Test /500 Test Description Hemoglobin (hemosiderin) is a hemoglobin-derived pigment, golden yellow or brown particles, because of its iron, golden yellow, it is called hemosiderin. When red blood cells are phagocytosed by macrophages, hemoglobin is broken down into iron-free orange blood and iron-containing hemosiderin under the action of lysosomal enzymes. Perls Prussian blue reaction (Prussian blue reaction), also known as hemosiderin staining, that is, after treatment of potassium ferrocyanide and dilute acid can produce blue, common in phagocytes or interstitial, the main display of ferric salt. Perls Prussian blue is a very classical histochemical reaction that is a sensitive, traditional and excellent method of displaying ferric iron in tissues. The staining principle is that potassium ferrocyanide makes the ferric ion from the protein diluted with hydrochloric acid Isolated, ferric iron and potassium ferrocyanide reaction to generate a blue insoluble compound that ferric ferricyanide Prussian blue, so the reaction is called Prussian blue reaction. Ferrous iron ferrocyanide is a very stable compound, after the reaction can be red dye staining, such as nuclear red, eosin, such as neutral red. Prussian blue - nuclear red staining kit commonly used to show that various local hemorrhagic lesions within the organization, common in phagocytes. In determining the hemosiderin deposition, Perls reaction can be confirmed, the staining method can be a good distinction between hemosiderin and other pigments. The dyeing liquid has good stability, can be stored for a long time, is not easy to produce precipitation, has a wide range of applications, can be counterstained.
    [Show full text]